<DOC>
	<DOCNO>NCT03025750</DOCNO>
	<brief_summary>The trial phase III , non-inferiority , observer-blind , randomise , active control , multicentre clinical trial 2 parallel group : IPV-Al SSI ( investigational vaccine ) IPV SSI ( comparator vaccine ) . The vaccine administer 2 , 4 6 month age .</brief_summary>
	<brief_title>Safety Immunogenicity Adjuvanted Reduced Dose Inactivated Polio Vaccine 2 , 4 , 6 Months Age</brief_title>
	<detailed_description>In addition trial vaccine ( IPV-Al SSI IPV SSI ) , trial subject receive concomitant childhood vaccination trial period . The trial vaccine ( IPV-Al SSI IPV SSI ) administer RIGHT thigh , whereas injectable childhood vaccine administer opposite ( LEFT ) thigh . At Visit 1 ( inclusion , screen , blood sample , randomisation 1st vaccination ) , write informed consent obtain subject 's eligibility assess accord pre-specified in-/exclusion criterion . Information medical history , demographic concomitant medication collect physical examination perform vital sign measure . A prevaccination blood sample take polio antibody determination subject randomly allocate one two vaccination group vaccinate . A subset 200 subject randomly choose extra blood sample take Visit 3 . The subject observe immediate AEs 30 minute vaccination . An eDiary , thermometer ruler hand parent measurement temperature record injection site reaction solicit systemic AEs . These activity perform daily , start day vaccination follow 2 day resolve , record AEs instructed trial staff . A contact parent via telephone make vaccination visit remind parent fill eDiary check question regard use eDiary . At Visit 2 ( 2nd vaccination ) , 2 month Visit 1 , eDiary collect AEs concomitant medication record . Contraindications review , 2nd vaccination administer , immediate reaction observe eDiary return partents recording AEs concomitant medication . A contact parent via telephone make vaccination visit remind parent fill eDiary check question regard use eDiary . At Visit 3 ( 3rd vaccination ) , 2 month Visit 2 , eDiary collect AEs concomitant medication record . A blood sample subset subject take polio antibody determination . Contraindications review , 3rd vaccination give , immediate reaction observe eDiary return parent . A contact parent via telephone make vaccination visit remind parent fill eDiary check question regard use eDiary . At Visit 4 ( blood sample trial completion ) , 1 month Visit 3 , eDiary collect AEs concomitant medication record blood sample polio antibody determination take . A safety follow-up telephone call conduct 12 month age .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants 2 month age ( 5475 day age ) date first vaccination Healthy assess medical history physical examination Parent ( ) /guardian ( ) properly inform trial sign informed consent form Parent ( ) /guardian ( ) grant access infant 's trial relate medical record Parent ( ) /guardian ( ) likely comply trial procedure Vaccinated polio vaccine trial vaccine , prior inclusion plan trial OPV vaccination know exposure poliovirus ( wild vaccinederived ) household ( live together ) within 3 month prior inclusion plan trial Low birth weight ( &lt; 2,500 g ) Known suspect immunodeficiency ( e.g . leukaemia , lymphoma ) family history congenital hereditary immunodeficiency . HIV infection exclusion criterion Severe uncontrolled chronic ( e.g . neurologic , pulmonary , gastrointestinal , hepatic , renal endocrine ) disease Known suspect allergy vaccine constituent ( e.g . hypersensitivity formaldehyde , aluminium 2phenoxyethanol ) Uncontrolled coagulopathy blood disorder contraindicate intramuscular injection blood sample Treatment product likely modify immune response ( e.g . systemic corticosteroid , blood product immunoglobulin ) prior inclusion plan trial period Participating another clinical trial Not suitable inclusion opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>54 Days</minimum_age>
	<maximum_age>75 Days</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>